文献速递乳腺癌

BRCA突变携带者早期乳腺癌对侧乳腺预防性照射

Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
PubMed 文献 · Ann Oncol · 2019-01-01

这项II期双臂比较试验纳入162例接受早期乳腺癌治疗的BRCA携带者,81例选择标准局部区域治疗(对照组),81例额外接受对侧乳腺照射(干预组)。中位随访58个月,对照组10例发生对侧乳腺癌(中位32个月),干预组2例分别于双侧乳腺照射后80和105个月发生(log-rank P=0.011)。

要点

  • 对照组10例发生对侧乳腺癌,干预组2例,log-rank P=0.011。
  • 对侧乳腺癌发生时间:对照组中位32个月,干预组为80和105个月。
  • 中位随访58个月,162例BRCA携带者纳入分析。

核心结论

  • 在接受早期乳腺癌治疗的BRCA携带者中,加用对侧乳腺照射与后续对侧乳腺癌的显著减少及发病延迟相关。

研究设计与样本

  • 经机构审查委员会批准的II期双臂比较试验(NCT00496288)。
  • 2007年5月至2017年10月共纳入162例接受早期乳腺癌治疗且拒绝对侧乳腺切除术的BRCA携带者。
  • 81例选择标准局部区域治疗(手术加患侧放疗,对照组),81例选择额外对侧乳腺照射(干预组)。
  • 主要终点为对侧乳腺癌。

主要发现

  • 中位随访58个月,对照组10例发生对侧乳腺癌,中位发生时间32个月。
  • 干预组2例发生对侧乳腺癌,分别于双侧乳腺照射后80和105个月发生。
  • 对侧乳腺癌发生率比较log-rank P=0.011。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women who carry germ-line mutations in BRCA1/2 are at very high risk of developing breast and ovarian cancer. Breast conserving therapy is associated with a similar risk of ipsilateral cancer recurrence in BRCA carriers compared with non-carriers. However, the risk of subsequent contralateral breast cancer in carriers is markedly increased. Therefore, mastectomy of the diseased breast along with risk reducing mastectomy of the contralateral breast is often advocated for BRCA carriers who are treated for early breast cancer. Yet, many BRCA carriers forgo this option for fear of harmful effects and choose breast conserving treatment and observation instead. In Israel, BRCA-associated breast cancer is relatively common. Accordingly, a national protocol was devised for this enriched population. PATIENTS AND METHODS: In this Institutional Review Board-approved phase II trial, the option of prophylactic irradiation to the contralateral breast, in addition to standard loco-regional treatment, was offered to BRCA carrier patients treated for early breast cancer who declined contralateral mastectomy. The primary end point was contralateral breast cancer. RESULTS: Between May 2007 and October 2017, 162 patients were enrolled. Eighty-one patients opted for standard loco-regional treatment including surgery and radiation to the involved side (control arm) and 81 patients chose additional contralateral breast irradiation (intervention arm). At a median follow-up of 58 months, 10 patients developed contralateral breast cancer in the control arm at a median of 32 months, as compared with 2 patients in the intervention arm who developed contralateral breast cancer 80 and 105 months after bilateral breast irradiation (log-rank P = 0.011). CONCLUSIONS: Among BRCA carrier patients treated for early breast cancer, the addition of contralateral breast irradiation was associated with a significant reduction of subsequent contralateral breast cancers and a delay in their onset. CLINICAL TRIAL: Phase II, comparative two-arm trial (NCT00496288).

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Evron E, Ben-David AM, Goldberg H, et al. Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer. Ann Oncol. 2019. PMID: 30475942. doi:10.1093/annonc/mdy515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。